GT Biopharma Inc. (GTBP)
NASDAQ · Manufacturing · Pharmaceutical preparations
$6.89+$0.0600 (+0.88%) on the dayAs of the close; data may be delayed.
GTBP price, last 12 months
Key stats
- Previous close
- $6.83
- Open
- $6.79
- Day range
- $6.59 – $7.24
- 52-week range
- $4.91 – $34.25
- Volume
- 79.8K
- Avg volume (20 days)
- 123.1K
- Market cap
- $12.4M
Performance
1W−3.8%
1M−5.0%
3M−35.9%
6M−38.2%
YTD−64.9%
1Y−65.6%
vs S&P 500, 1Y−82.3 pts
Technicals and fundamentals
About GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $12.4M